Latuda and Hair loss - a phase IV clinical study of FDA data

Summary:

Hair loss is reported as a side effect among people who take Latuda (lurasidone hydrochloride), especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months also take Lamictal, and have Stress and anxiety.

The phase IV clinical study analyzes which people have Hair loss when taking Latuda. It is created by eHealthMe based on reports of 20,677 people who have side effects when taking Latuda from the FDA, and is updated regularly.

What is Latuda?

Latuda has active ingredients of lurasidone hydrochloride. It is often used in bipolar disorder. eHealthMe is studying from 21,543 Latuda users. Check the latest studies of Latuda.

What is Hair loss?

Hair loss is found to be associated with 2,411 drugs and 3,511 conditions by eHealthMe. Check the latest studies of Hair loss.

On May, 17, 2026

20,677 people reported to have side effects when taking Latuda.
Among them, 97 people (0.47%) have Hair loss.

Among these 97 people:

How long have people been on Latuda when they have Hair loss? *

What is the gender of people who have Hair loss when taking Latuda? *

female: 89.29 %
male: 10.71 %

What is the age of people who have Hair loss when taking Latuda? *

What are other drugs people take besides Latuda? *

What are other side effects people have besides Hair loss? *

Weight Increased: 11 people, 11.34%
Stress And Anxiety: 8 people, 8.25%
Insomnia (sleeplessness): 7 people, 7.22%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 5 people, 5.15%
Tremor (trembling or shaking movements in one or more parts of your body): 5 people, 5.15%
Itching: 5 people, 5.15%
Fatigue (feeling of tiredness): 5 people, 5.15%
Psychological Trauma: 4 people, 4.12%
Speech Disorder: 4 people, 4.12%
Dyspnea (difficult or laboured breathing): 4 people, 4.12%

What are the existing conditions these people have? *

Stress And Anxiety: 9 people, 9.28%
Breast Cancer Female: 7 people, 7.22%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 5.15%
Pain: 4 people, 4.12%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 4 people, 4.12%
Breast Cancer: 4 people, 4.12%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 4 people, 4.12%
High Blood Pressure: 4 people, 4.12%
Diabetes: 3 people, 3.09%
Psychotic Disorder: 3 people, 3.09%

* Approximation only. Some reports may have incomplete information.

Do you take Latuda and have Hair loss?

- Check whether Hair loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Latuda:

Latuda (21,543 reports)

Hair loss treatments and more:

Hair loss (271,201 reports)

Browse all side effects of Latuda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hair loss:

Hair loss (2,411 drugs)

Browse all the conditions that are associated with Hair loss:

Hair loss (3,511 conditions)

Related publications that referenced our studies

Reddy, B., Das, S., & Ali, M. , "A Case of Hypersexuality Probably Associated With Lurasidone", Journal of clinical psychopharmacology, 2018 Jan .
Sood S, "Neutropenia with Multiple Antipsychotics Including Dose Dependent Neutropenia with Lurasidone", Clinical Psychopharmacology and Neuroscience, 2017 Jan .
Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .
Reddy, B., Das, S., & Ali, M. , "A Case of Hypersexuality Probably Associated With Lurasidone", Journal of clinical psychopharmacology, 2018 Jan .
Sood S, "Neutropenia with Multiple Antipsychotics Including Dose Dependent Neutropenia with Lurasidone", Clinical Psychopharmacology and Neuroscience, 2017 Jan .
Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on lurasidone hydrochloride (the active ingredients of Latuda) and Latuda (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.